Rebif Rebidose Solution For Injection 22Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Rebif Rebidose: Solution for injection (22mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

INTERFERON BETA-1a (in ter FEER on BAY ta wun aye) helps to decrease the number of multiple sclerosis attacks and to slow physical disability in people with relapsing forms of the disease. The medicine does not cure multiple sclerosis.

In-Depth Information

Rebif Rebidose 22mcg/0.5mL Solution for Injection

NDC: 440873322
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Sometimes used for but not FDA approved for the following conditions:
Hepatitis C Infection, Multiple Sclerosis

Storage Information
Avoid exposure to heat
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Discard unused portion. Do not store for later use.
Do not freeze
May be stored between 36 to 77 degrees F, away from heat and light, for up to 30 days if refrigeration is not available
Rebif Rebidose 22mcg/0.5mL Solution for Injection

Reported Side Effects for Rebif Rebidose 22mcg/0.5mL Solution for Injection

Dry Eyes Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Tissue Death Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: EARLY
Increased Urination Incidence:
2.0-7.0%*
Severity: MILD
Onset: EARLY
Peripheral Vasodilation Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Low Platelet Count Incidence:
2.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Uncontrolled Urination Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: EARLY
High Bilirubin Level Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
3.0-92.0%*
Severity: MILD
Onset: RAPID
Anemia Incidence:
3.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
4.0-5.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
4.0-5.0%*
Severity: MILD
Onset: EARLY
Thoughts Of Suicide Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Excessive Sweating Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Overactive Thyroid Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Underactive Thyroid Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Antibody Formation Incidence:
5.0-31.0%*
Severity: MODERATE
Onset: DELAYED
Chest Pain Incidence:
5.0-8.0%*
Severity: MODERATE
Onset: EARLY
Migraine Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
6.0%*
Severity: MODERATE
Onset: EARLY
Excessive Mucle Tone Incidence:
6.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Visual Impairment Incidence:
7.0-13.0%*
Severity: SEVERE
Onset: EARLY
Infection Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
8.0-22.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
9.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
10.0-27.0%*
Severity: MODERATE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
10.0-15.0%*
Severity: MILD
Onset: EARLY
Enlarged Lymph Nodes Incidence:
11.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
14.0%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
19.0%*
Severity: MILD
Onset: RAPID
Fever Incidence:
20.0-28.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
20.0-25.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
23.0-25.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
23.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
24.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
24.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
25.0-29.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
28.0-36.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
33.0-41.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
58.0-70.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Rebif Rebidose 22mcg/0.5mL Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Alcohol and Rebif Rebidose 22mcg/0.5mL Solution for Injection(Interferon Beta-1a (Hamster))
Alcohol and Interferon Beta-1a (Hamster)(Interferon Beta-1a (Hamster))
Side effects from Interferon Beta-1a, such as liver damage, may be more likely if you take Ethanol. Avoid taking alcoholic beverages during treatment with Interferon Beta-1a.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Rebif Rebidose

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5